The American Academy Of Pain Medicine

The physicians' voice in pain medicine
  • Foundation
  • Store
  • Career Center
  • Press
  • Join-Renew
Search: Go
Member Login: Login

Enter the AAPM
Members' Community

  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Safe Prescribing Resources
  • PI-CME Portal

Library

Home > Library > For Pain Researchers > 2012 Poster Abstracts
  • Research in the News
  • For Pain Researchers
    • 2013 Poster Abstracts
    • 2012 Poster Abstracts
    • Research Resources
    • Research Presentations
    • Search Clinical Trials (NIH)
    • Register a Clinical Trial (NIH)
    • Medline - US National Library of Medicine
  • Clinical Guidelines and Resources
  • Pain Facts
  • Archives
  • FDA Updates, Recalls and Warnings
  • Presented at the 2012 AAPM Annual Meeting « Back

    217

    Identification of Key Gaps in Opioid Prescriber Knowledge with an Industry-Sponsored REMS Credentialing Test

    Maria Frazer, BS, maria_frazer@urmc.rochester.edu1, John Markman, MD2, Rui Hu, PhD3, Mackenzie A. Tsang-Lee1, Katarzyna Czerniecka, MD1, (1) University of Rochester, Rochester, New York, (2) Department of Neurosurgery, University of Rochester School of Medicine, Rochester, New York, (3) Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York

    Introduction: Industry-sponsored educational programs are the centerpiece of FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) for long-acting opioid medication. This cross sectional survey identifies key gaps in knowledge related to opioid pharmacology and risk management practices among a diverse group of clinicians who routinely prescribe this class of medication. Methods: A questionnaire related to opioid prescribing with an embedded subset of post-test items from the program of a long-acting opioid manufacturer was administered to 31 prescribers (13 MDs, 2 DOs, 15 NPs, 1 PA) in attendance at a regional pain management conference. Survey items included multiple choice questions pertaining to fund of knowledge, attitude, and current practice. These data represent a baseline dataset for the participants in this educational activity. Results: Sixty-eight percent of respondents answered fewer than five of seven post-test questions correctly. Ninety-seven percent of prescribers incorrectly answered items pertaining to safe initial titration of an extended release long-acting opioid (ER LAO). Fewer than 60% of prescribers demonstrated an understanding of best practices related to safe storage of ER LAOs. Prescribers who recognized the risks factors for addiction were also more likely to understand the primary risks of ER LAOs (p = 0.02). The associations between responses were tested by Fisher’s exact test. Conclusion: An industry-sponsored REMS post-test identifies key knowledge gaps in clinicians who routinely prescribe opioids. Based on these preliminary results, educational programs and credentialing programs should emphasize fund of knowledge deficits related to initial titration and safe storage of long-acting opioid products.

    Funding: This research was partially funded by a grant from Endo Pharmaceuticals.

  • Home
  • Member Center
  • Patient Center
  • Library
  • Advocacy
  • Practice Management
  • CME
  • Annual Meeting
  • Contact Us
  • Members' Community
  • Privacy Policy
  • Sitemap
Close

Members Only Alert Message

Please login to access AAPM member only information.
Forgot your login information?

Sign Up Today!

Join AAPM today and be part of the primary organization for physicians practicing in the specialty of pain medicine and begin accessing AAPM member benefits. 

Join
Or

Log In

Please log in and you will be redirected to the requested page.

Log In